MARCO is an IFN-restricted immunometabolic decoy LPS receptor 2308885

S Shriram Ramani S Sara Cahill (Division of Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School) M Matthew Finnegan (UMass Chan Medical School) L Laurel Stine (Division of Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School) A Abigail Sondrini (UMass Chan Medical School) K Kiera Clayton (UMass Chan Medical School) L Liraz Shmuel-Galia (Division of Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School) F Fiachra Humphries

Abstract

Abstract Introduction Cytosolic sensing of bacterial lipopolysaccharide (LPS) is mediated by caspase-11 (caspase-4/5 in humans), which triggers non-canonical inflammasome activation. This leads to gasdermin D cleavage, pyroptosis, and release of pro-inflammatory cytokines. Severe gram-negative bacterial infections cause endotoxic septic shock, with systemic inflammation, organ failure, and potential death. Bacterial derived LPS gains access to the cytosol through extracellular vesicles and CD14 receptor mediated endocytosis. However, how this process is controlled during infection to maintain homeostasis is unknown. Methods We performed an unbiased proteomic screen with biotinylated LPS and identified MARCO as an LPS-binding protein by mass spectrometry. Using macrophages from transgenic mice, we defined the mechanism by which MARCO facilitates LPS clearance to limit activation of the non-canonical inflammasome. Results MARCO is a scavenger receptor expressed on tissue resident macrophages (TRMs) and is known to promote clearance of pathogens and apoptotic debris. However, there is a lack of genetic studies and a paucity in our understanding of the functional role MARCO plays in innate immunity and how MARCO expression is regulated on TRMs. Here, we show that activation of the non-canonical inflammasome is preceded by a priming step by which type I interferon (IFN) suppresses MARCO expression on TRMs to allow for optimal recognition of LPS and activation of caspase-11. Remarkably, the metabolite itaconate and transcription factor NRF2 mediate MARCO expression. IFN signaling inhibits NRF2 stabilization, reducing surface MARCO levels. In vivo, MARCO-deficient mice show increased sensitivity to LPS-induced septic shock due to enhanced caspase-11 and non-canonical inflammasome activation. Conclusion IFN-mediated suppression of MARCO expression is a previously unknown innate checkpoint that facilitates the recognition of LPS by caspase-11, activation of the non-canonical inflammasome, and progression of septic shock. Funding Source n/a Topic Categories Innate Immune Responses and Host Defense: Molecular Mechanisms (INM)

Article Details

Volume / Issue Vol. 215, Issue Supplement_1
Published August 01, 2026
ISSN 0022-1767
Publisher American Association of Immunologists

Authors (8)

S

Shriram Ramani

S

Sara Cahill

Division of Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School

M

Matthew Finnegan

UMass Chan Medical School

L

Laurel Stine

Division of Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School

A

Abigail Sondrini

UMass Chan Medical School

K

Kiera Clayton

UMass Chan Medical School

L

Liraz Shmuel-Galia

Division of Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School

F

Fiachra Humphries